Manas AI, a NYC-based AI native drug discovery and development company, raised $26M in Seed extension funding. Backers included The General Partnership, Wisdom Ventures, Blitzscaling Ventures, Westbound Equity Partners, Mosaic Ventures, and others. The company intends to use the funds to accelerate the development of its drug discovery foundational models and advance its current therapeutic campaigns. Co-founded by Dr. Siddhartha Mukherjee, Reid Hoffman, and Ujjwal Singh, Manas AI builds and uses neuro-symbolic, science-based foundational models to discover and bring transformative medicines to market. The Seed extension followed a $24.6M Seed round in January of this year led by General Catalyst and Reid HoffmanFinSMEs23/09/2025